Role of CXCR4 and VEGF expression and metastatic locoregional lymphnodes in rectal carcinoma Tatangelo F.*, Avallone A.**, Delrio P.°, Scala S.§, Botti.

Slides:



Advertisements
Similar presentations
Changes in mitochondrial shape and distribution in gastric carcinoma: A morphologic, Immunohistochemical and ultrastructural study. Caruso RA, Napoli P.
Advertisements

Polyps – Where do they come from and what do you do with them?!
Management of Malignant Polyps Santhat Nivatvongs, MD Colon and Rectal Surgery Mayo Clinic Rochester Minnesota U.S.A.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Cyclooxygenase-2 (COX-2) overexpression is associated with a poor prognosis in chondrosarcomas Makoto Endo, 1 Tadaki Matsumura, 2 Umio Yamaguchi, 1 Fumihiko.
Cancer-stroma interactions: role of cancer-associated fibroblasts and mast cells in breast carcinogenesis A Malfettone 1, G Simone 2, R Rossi 3, C Salvatore.
How to get more nodes in laparoscopic colon surgery John Marks MD Chief Division of Colorectal Surgery Lankenau Hospital and Institute of Medical Research.
Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee.
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
The 70 gene Mammaprint ™ signature: a comparison with traditional clinico-pathological parameters. Patrizia Querzoli 1, Massimo Pedriali 1, Gardenia Munerato.
CXCR4 receptor is correlated to the development of metastases in leiomyosarcoma, pleomorphic sarcoma and liposarcoma S.C.D.U. Medical Oncology I.R.C.C.
G.Liguori,G.Pirozzi^, I. Forte, G.Botti, R.Franco, A.La Rocca*, G.Rocco* Istituto Nazionale Tumori Napoli Dip.Anatomia Patologica; Dip.Onc.Sperimentale^;
Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-regulation of Calreticulin Expression Speaker: Yi-Chien.
Na + /H + exchanger regulatory factor 1 (NHERF1) and angiogenesis in familial breast cancer A Mangia*, A Malfettone*, C Salvatore**, B Stea*, G Simone**
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 lymphnodes A.Ieni, A. Simone, G. Neri, V. Barresi, G. Giuffrè, B.
A Quantitative Multi-Gene RT-PCR Assay for Prediction of Recurrence in Stage II Colon Cancer (CC): Selection of the Genes in 4 Large Studies and Results.
Pfetin, as a Prognostic Biomarker of Gastrointestinal Stromal Tumors Revealed by Proteomics Yoshiyuki Suehara 1 3 4, Kunihiko Seki 2, Kiyonaga Fujii 1,
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Survivin and XIAP expression in multiple pulmonal metastases from renal cell carcinoma (RCC) patients: results of tissue micro array (TMA) studies P. Schneider.
INCREASED EXPRESSION OF PROTEIN KINASE CK2  SUBUNIT IN HUMAN GASTRIC CARCINOMA Kai-Yuan Lin 1 and Yih-Huei Uen 1,2,3 1 Department of Medical Research,
Investigation of CA9 expression in pulmonary metastatic lesions from patients with clear cell renal cell carcinoma Pierre Tennstedt 1, Peter Schneider.
INTESTINAL DIFFERENTIATION IN PULMONARY ADENOCARCINOMA Paul Theunissen, MD, PhD, Nick van Rodijnen, Dept. of pathology, Atrium Medisch Centrum, Heerlen,
Tumor clock protein PER2 as a determinant of survival in patients (pts) receiving oxaliplatin-5-FU- leucovorin as 1st line chemotherapy for metastatic.
IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C*, Saccani S*, Lai ML*, Pilloni L*, Coni PP*, Senes G*, Faa G*, Van den Oord JJ°. *I Cattedra.
EXPRESSION OF HER-2 CORRELATED PROTEINS IN ILEAL CARCINOIDS Azzoni C., Giordano G., Bottarelli L., Tamburini E., D’Adda T., Pizzi S., Rindi G., Bordi C.
HOMING Ewing vs Paget Trapping vs homing (controlled arrest) “Seed and soil” Organ-specific metastatic colonization of favorable microenvironment.
Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
The role of regulatory B cells on hepatocellular carcinoma progression Conclusion Results Fig2. (A and B) In vivo, Bregs in SCID mice increased the size.
Factors affecting failed localisation and false-negative rates of ex-vivo sentinel lymph node mapping in colorectal cancer. Sommariva A, Gnocato B, Tollot.
Non ‐ invasive prognostic protein biomarker signatures associated with colorectal cancer by Silvia Surinova, Lenka Radová, Meena Choi, Josef Srovnal, Hermann.
Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,
EXPRESSION OF ABERRANT p53 PROTEIN IN GASTRIC CANCER
Authors: Puccio I. 1; Butt MA1, 2; Oukrif D4; Khan S 1; Haidry RJ
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
Wijendra Senarathne1, Peggy Gates1, Semir Vranic2, Zoran Gatalica1
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Breast cancer cutaneous metastases: implications of MUC1 and
EMT inducing transcription factor SIP1: a predictive biomarker of colorectal cancer survival and recurrence? A Patel, R Sreekumar, R Bhome, KA Moutasim,
Vascular Endothelial Growth Factor VEGF and p53 Expression in Tunisian Patients with Pterygium: Immunohistochemical Analysis O Beltaief, Kh Errais, I Ammous,
Anti-Aging Therapy With Human Growth Hormone Associated With Metastatic Colon Cancer in a Patient With Crohn’s Colitis  Gil Y. Melmed, Shane M. Devlin,
Bedside to Bench: Role of Muscarinic Receptor Activation in Ultrarapid Growth of Colorectal Cancer in a Patient With Pheochromocytoma  Erik C. von Rosenvinge,
Dr T P E Wells 13 July 2018 Breast SSG Bath
Nat. Rev. Clin. Oncol. doi: /nrclinonc
C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis  Tie Wang, Yuzhe.
HOMING
KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers  Katharina Balschun, Jochen Haag, Ann-Kathrin.
Figure 2 The association between CD8+ T‑cell density of the tumour
Nat. Rev. Urol. doi: /nrurol
PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.
Volume 117, Issue 2, Pages (August 1999)
Treatment Overview: The Multidisciplinary Team
Published online September 20, 2017 by JAMA Surgery
Volume 67, Issue 4, Pages (April 2005)
Poster session n. 2.
Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non- small Cell Lung Cancer  Tomofumi Yohena, MD, Ichiro Yoshino, MD,
Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma  Po-Kuei Hsu, MD,
Expression of vascular endothelial growth factor in thoracic sarcomas
Healthy volunteers (n=28) P value CRC patients         (n=30) ±9.3
Changes in TNM 8 To be used from
FAK overexpression in invasive human colon cancer and colon dysplasia.
IL-13Rα2 expression is associated to human colon cancer progression and poor survival of patients with colorectal cancer. IL-13Rα2 expression is associated.
MPGES is expressed in epithelial cells in benign and malignant tumors of the colon. mPGES is expressed in epithelial cells in benign and malignant tumors.
Immunohistochemical detection of nuclear and cytoplasmic YB-1 in osteosarcoma and synovial sarcoma. Immunohistochemical detection of nuclear and cytoplasmic.
Immunohistochemical analysis of dUTPase in human breast adenocarcinoma
Immunohistochemical staining of primary and metastatic prostatic carcinomas with anticyclin D1 and anti-Ki67 monoclonal antibodies. Immunohistochemical.
Immunohistochemical determination of TIM-3 expression in ccRCC.
Expression of the angiogenic phenotype in the 4-NQO mouse model of HNSCC. A, tissue sections containing areas of normal, hyperkeratosis, dysplasia, and.
Presentation transcript:

Role of CXCR4 and VEGF expression and metastatic locoregional lymphnodes in rectal carcinoma Tatangelo F.*, Avallone A.**, Delrio P.°, Scala S.§, Botti G.* S.C. Anatomia Patologica ITN, Napoli ** Oncologia Medica,D.to Entero-proctologico ITN, Napoli ° Oncologia Chirurgica, D.to Entero-proctologico ITN, Napoli § Immunologia, ITN, Napoli

Introduction Chemokine receptors are known to be involved in the lymphatic spread of many solid tumors, while VEGF is implicated in metastatic process. Their role in the prediction of lymphnode spread and distant metastasis in colorectal carcinoma could be of great importance for the selection of rectal carcinoma patients with worst prognosis.

Objectives To evaluate the expression of CXCR4(receptor of chemokine CXCL12) and VEGF(Vascular endothelial Growth Factor) in rectal carcinoma and their relationship with other biological and pathological parameters of prognostic value

Materials and methods-1 N. 70 cases of stage II-III rectal carcinoma operated in our institution from were examined using routine methods (e/e staining) and immunohistochemical techniques for CXCR4, VEGF, p53 and TS106 detection, on formalin fixed and paraffin embedded specimens.

Materials and methods-2 Multiple e/e stained sections of tumor and its related lymphnodes were examined All 70 patients were clinically R0 after surgery. Receptor expression (absent vs positive) of the overall tumor was related to other pathological parameters of prognostic value: -pT(according UICC) -grading -pN(according UICC) -lymphovascular invasion

Materials and methods-3 Antibodies used for immunohistochemical staining: -anti CXCR4, clone 44716, R&D system, Minneapolis -anti VEGF, clone VG1, DAKO -anti TS106, ZYMED -anti p53, Novocastra

Results-1 Normal mucosa was not immunoreactive for CXCR4,VEGF, TS106 and p53. CXCR4 expression was + in 55 cases(78,5%) VEGF expression was + in 43 cases(61, 4%) TS106 expression was + in 65 cases(92,8%) P53 expression was + in 68 cases(97,1%)

Results-2 Table 1 shows the correlation between CXCR4 and VEGF expression and some pathologic parameters, as pT, Grading, pN and lymphovascular invasion(LVI)

Table 1 - Correlation between CXCR4 and VEGF expression and other pathologic parameters n. CXCR4 VEGF pT pT G G pN pN pN LVI – LVI

Results-3 There is significant correlation between CXCR4 and VEGF expression and depth of invasion(pT), metastatic lymphnodes(pN) and LVI. CXCR4 and VEGF expression was related to TS106 and p53 expression too

P 53 expression in neoplastic cells related to normal mucosa TS106 expression in neoplastic cells IIC staining for p53 and TS106 in rectal carcinoma

Strong cytoplasmic positivity of CXCR4 IIC staining for CXCR4 in rectal carcinoma

Cytoplasmic positivity of VEGF IIC staining for VEGF in rectal carcinoma

Conclusion Lymphnode status is related to lymphovascular invasion and to CXCR4, VEGF, TS106 and p53 expression. Notably, high expression of CXCR4 and VEGF was significantly associated with metastatic lymphnodal status and, then, with poor prognosis in rectal cancer patients. Further studies are necessary to clarify the real role of these molecules in invasive and metastatic process in rectal carcinoma.

References: -Baggiolini M, Dewald B, Moser B, Human chemokines: an update, Annu Rev Immunol, Maeda K, Yashiro M et al., Correlation between VEGF expression and lymphnode metastasis in carcinoma of the colon and rectum Surg today, Yoshitake et al., Expression of SDF-1 and CXCR4 predicts lymphnode metastasis in crc BJC, 2008